Skip to main content
. Author manuscript; available in PMC: 2012 Apr 28.
Published in final edited form as: J Med Chem. 2011 Mar 23;54(8):2792–2804. doi: 10.1021/jm101593u

Table 1.

Antiparasitic, antibacterial and cytotoxic activities of semisynthetic erythromycin analogues.

Cmpd. # IC50 (μM) T. gondii MIC (μM) B. subtilis CC50 (μM)
1 Erythromycin 93 ± 10 0.04 475
2 Clarithromycin 31 ± 5 0.04 260
3 Azithromycin 20 ± 2 0.15 174

R1
graphic file with name nihms283584t1.jpg 4 graphic file with name nihms283584t2.jpg 14 ± 2 0.04 22
5 graphic file with name nihms283584t3.jpg 1.6 ± 0.2 0.04 7
6 graphic file with name nihms283584t4.jpg 2.7 ± 1 0.04 16
7 graphic file with name nihms283584t5.jpg 1.4 ± 0.1 0.04 3

R2
graphic file with name nihms283584t6.jpg 8 graphic file with name nihms283584t7.jpg 65 ± 7 1.2 386
9 graphic file with name nihms283584t8.jpg 16 ± 3 0.6 139
10 graphic file with name nihms283584t9.jpg 13 ± 2 0.3 103
11 graphic file with name nihms283584t10.jpg 2 ± 0.2 0.3 32
12 graphic file with name nihms283584t11.jpg 85 ± 3 10 480
13 graphic file with name nihms283584t12.jpg 12 ± 0.3 1.2 222

R3
graphic file with name nihms283584t13.jpg 14 graphic file with name nihms283584t14.jpg 106 ± 11 2.5 460
15 graphic file with name nihms283584t15.jpg 89 ± 7 5 454
16 graphic file with name nihms283584t16.jpg 20 ± 2 1.2 106
17 graphic file with name nihms283584t17.jpg 13 ± 1 0.8 84
18 graphic file with name nihms283584t18.jpg 2 ± 0.1 0.3 13
19 graphic file with name nihms283584t19.jpg 59 ± 4 10 409
20 graphic file with name nihms283584t20.jpg 16 ± 0.4 1.5 62

R4
graphic file with name nihms283584t21.jpg 21 graphic file with name nihms283584t22.jpg 40 ± 1 2.5 74
22 graphic file with name nihms283584t23.jpg 25 ± 0.7 10 96
23 graphic file with name nihms283584t24.jpg 15 ± 0.6 10 42
24 graphic file with name nihms283584t25.jpg 12 ± 0.4 5 38
25 graphic file with name nihms283584t26.jpg 5 ± 0.3 6 14
26 graphic file with name nihms283584t27.jpg 33 ± 2 5 90
27 graphic file with name nihms283584t28.jpg 6 ± 0.4 1.5 28

To quantify the antiparasitic activity of each compound, cultures of human foreskin fibroblast (HFF) cells grown in 96-well plates were infected with T. gondii cells 2F-1 YFP2 (T. gondii YFP) 36 expressing the yellow fluorescent protein under control of a constitutive promoter. Each compound was titrated into infected cultures at varying dilutions. Infected cultures were incubated for 4 days (2 infection cycles) in the continuous presence of compounds. Antibacterial activity was measured as the minimum inhibitory concentration (MIC) against the representative Gram-positive bacterium B. subtilis. Two-fold incremental dilutions of each compound were added to freshly inoculated cultures of B. subtilis. The lowest concentration at which no growth was observed was recorded as the MIC value. Cytotoxicity was determined in parallel with antibacterial and antiparasitic activity with MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxylmethoxylphenyl)-2H-tetrazolium) assay. Low passage HFF cells (2 × 103 cells/well) were seeded into the 96-well culture plates, and incubated for 24h at 37 °C. Then, the HFF cells were exposed to the various concentrations of macrolides for 2 days. After incubation, the macrolide treated medium was aspirated, and fresh medium and MTS were added in order. The plates were incubated for 4h at 37 °C, and the optimal density was measured at 490nm. CC50 was determined by cytotoxic dose of macrolides reducing cell viability by 50%.